InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-40.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by HighCape Capital, L.P.. Officer active across 2 companies, notably Aziyo Biologics, INC.. Cumulatively, 7 reports have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €6.7m. History available since 8 December 2021. The latest transaction was disclosed on 3 February 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to HighCape Capital, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
420,000 shares@ US$2.5021.2% of flowClass A Common StockSEC:0001104659-25-023488:0
Canonical exit: 4 May 2025 (T+90)
420,000 shares@ US$2.5021.2% of flowClass A Common StockSEC:0001104659-25-023484:0
Canonical exit: 4 May 2025 (T+90)
2,101,577 shares@ US$1.427557.5% of flowClass A Common StockSEC:0001104659-24-084967:0
1,436,077 sharesClass A Common StockSEC:0001104659-24-002239:0
2,837,128 sharesClass A Common StockSEC:0001826279-23-000002:0
Canonical exit: 20 Dec 2021 (T+90)
735,000 shares@ US$4.7555.4% of flowClass A Common StockSEC:0001104659-22-125197:0
Canonical exit: 5 Mar 2023 (T+90)
353,773 shares@ US$4.2428.7% of flowClass A Common StockSEC:0001104659-21-148591:0
Canonical exit: 8 Mar 2022 (T+90)
7 of 7 declarations
About HighCape Capital, L.P.
HighCape Capital, L.P. is a declarant linked to ELUTIA INC. and Aziyo Biologics, INC., where it is a director. It has 7 filings in total, and across the 7 sampled filings, buys amount to EUR 6690486 and sells to EUR 0, over the period from 2021-12-10 to 2025-03-13, with the modal transaction nature listed as Acquisition.
